See also this year's filing and all EDGAR filings for this company.
PDF Report 0001062822_2025_Lexicon_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 318.25, 'aggregate_val': 49803000, 'exp_sum': 156000, 'exp_to_value': {'remainder_Revenues': 156000}} |
Graph
Absolute values for 0001062822, Lexicon Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 246,193,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,484,000 |
| 3 | remainder_Assets | 5,200,000 |
| 4 | LiabilitiesCurrent | 45,248,000 |
| 5 | LiabilitiesNoncurrent | 107,222,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 824,423 |
| 8 | SellingGeneralAndAdministrativeExpense | 162,513,888 |
| 9 | ResearchAndDevelopmentExpense | 77,841,455 |
| 10 | remainder_Expenses | 15,350,460 |
| 11 | remainder_Revenues | 21,926,818 |
| 12 | remainder_NetIncome | 10,714,236 |
| 13 | remainder_ComprehensiveNetIncome | 253,474 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 298,420,000 |
| 1 | Liabilities | 152,470,000 |
| 2 | Expenses | 256,530,226 |
| 3 | Revenues | 21,926,818 |
| 4 | StockholdersEquity | 145,950,000 |
| 5 | NetIncome | -223,889,172 |
| 6 | ComprehensiveNetIncome | -223,762,435 |
| 7 | BaseVar | 370,157,377 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.419 |
| 9 | EconomicCapitalRatio | 1.81 |
Edgar->Model Mapping
Feature Distribution
Change over Time
